Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients

PA-824 is a novel nitroimidazo-oxazine being evaluated for its potential to improve tuberculosis (TB) therapy. This randomized study evaluated safety, tolerability, pharmacokinetics, and extended early bactericidal activity of PA-824 in drug-sensitive, sputum smear-positive, adult pulmonary tubercul...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Diacon, Andreas H., Dawson, Rodney, Hanekom, Madeleine, Narunsky, Kim, Maritz, Stefan J., Venter, Amour, Donald, Peter R., van Niekerk, Christo, Whitney, Karl, Rouse, Doris J., Laurenzi, Martino W., Ginsberg, Ann M., Spigelman, Melvin K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916303/
https://ncbi.nlm.nih.gov/pubmed/20498324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01354-09
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia